• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转甲状腺素蛋白聚集及毒性的机制。

Mechanisms of transthyretin aggregation and toxicity.

作者信息

Gasperini Robert J, Klaver David W, Hou Xu, Aguilar Marie-Isabel, Small David H

机构信息

Menzies Research Institute, University of Tasmania, Liverpool Street, 7001, Hobart, TAS, Australia,

出版信息

Subcell Biochem. 2012;65:211-24. doi: 10.1007/978-94-007-5416-4_9.

DOI:10.1007/978-94-007-5416-4_9
PMID:23225005
Abstract

Amyloidoses are characterised by the deposition of insoluble protein that occurs in the extracellular compartment of various tissues. One form of amyloidosis is caused by transthyretin (TTR) misfolding and deposition in target tissues. It is clear that many amyloidoses share common features of fibrillogenesis and toxicity. This chapter examines the mechanisms of TTR aggregation with a view to understanding the possible therapeutic interventions in amyloid disease.

摘要

淀粉样变性的特征是不溶性蛋白质沉积在各种组织的细胞外区室中。一种淀粉样变性形式是由转甲状腺素蛋白(TTR)错误折叠并沉积在靶组织中引起的。很明显,许多淀粉样变性具有共同的纤维形成和毒性特征。本章研究TTR聚集的机制,以期了解对淀粉样疾病可能的治疗干预措施。

相似文献

1
Mechanisms of transthyretin aggregation and toxicity.转甲状腺素蛋白聚集及毒性的机制。
Subcell Biochem. 2012;65:211-24. doi: 10.1007/978-94-007-5416-4_9.
2
Transthyretin Misfolding, A Fatal Structural Pathogenesis Mechanism.转甲状腺素蛋白错误折叠:致命的结构发病机制。
Int J Mol Sci. 2021 Apr 23;22(9):4429. doi: 10.3390/ijms22094429.
3
Specific disruption of transthyretin(105-115) fibrilization using "stabilizing" inhibitors of transthyretin amyloidogenesis.使用“稳定”的转甲状腺素蛋白淀粉样变抑制剂特异性破坏转甲状腺素蛋白(105-115)纤维形成。
Biochemistry. 2012 Apr 24;51(16):3523-30. doi: 10.1021/bi3002727. Epub 2012 Apr 12.
4
Doxycycline disrupts transthyretin amyloid: evidence from studies in a FAP transgenic mice model.强力霉素破坏转甲状腺素蛋白淀粉样蛋白:来自家族性淀粉样多神经病转基因小鼠模型研究的证据。
FASEB J. 2006 Feb;20(2):234-9. doi: 10.1096/fj.05-4509com.
5
Familial amyloidotic polyneuropathy and transthyretin.家族性淀粉样多神经病与转甲状腺素蛋白
Subcell Biochem. 2012;65:565-607. doi: 10.1007/978-94-007-5416-4_21.
6
The importance of a gatekeeper residue on the aggregation of transthyretin: implications for transthyretin-related amyloidoses.一个守门残基对转甲状腺素蛋白聚集的重要性:对转甲状腺素蛋白相关淀粉样变性的影响
J Biol Chem. 2014 Oct 10;289(41):28324-37. doi: 10.1074/jbc.M114.563981. Epub 2014 Aug 1.
7
Relationship between amyloid deposition and intracellular structural changes in familial amyloidotic polyneuropathy.家族性淀粉样多发性神经病中淀粉样沉积与细胞内结构变化的关系。
Hum Pathol. 2012 Jan;43(1):96-104. doi: 10.1016/j.humpath.2011.01.036. Epub 2011 Jul 20.
8
[Transthyretin-related amyloidotic cardiomyopathy: looking for the etiological treatment].[转甲状腺素蛋白相关淀粉样变心肌病:寻找病因治疗]
G Ital Cardiol (Rome). 2014 May;15(5):293-300. doi: 10.1714/1563.17027.
9
Uncovering the Mechanism of Aggregation of Human Transthyretin.揭示人类转甲状腺素蛋白的聚集机制。
J Biol Chem. 2015 Nov 27;290(48):28932-43. doi: 10.1074/jbc.M115.659912. Epub 2015 Oct 12.
10
Cryo-EM structure of a transthyretin-derived amyloid fibril from a patient with hereditary ATTR amyloidosis.遗传性转甲状腺素淀粉样变性患者源性转甲状腺素蛋白衍生淀粉样纤维的冷冻电镜结构。
Nat Commun. 2019 Nov 1;10(1):5008. doi: 10.1038/s41467-019-13038-z.

引用本文的文献

1
A Brief Journey through Protein Misfolding in Transthyretin Amyloidosis (ATTR Amyloidosis).浅析转甲状腺素蛋白淀粉样变性(ATTR 淀粉样变性)中的蛋白错误折叠。
Int J Mol Sci. 2021 Dec 6;22(23):13158. doi: 10.3390/ijms222313158.
2
Divergence Entropy-Based Evaluation of Hydrophobic Core in Aggressive and Resistant Forms of Transthyretin.基于发散熵的转甲状腺素蛋白侵袭性和抗性形式疏水核心评估
Entropy (Basel). 2021 Apr 13;23(4):458. doi: 10.3390/e23040458.
3
Molecular signaling involving intrinsically disordered proteins in prostate cancer.
前列腺癌中涉及内在无序蛋白质的分子信号传导
Asian J Androl. 2016 Sep-Oct;18(5):673-81. doi: 10.4103/1008-682X.181817.
4
Wrecked regulation of intrinsically disordered proteins in diseases: pathogenicity of deregulated regulators.在疾病中,固有无序蛋白质的调节失控:失调调节剂的致病性。
Front Mol Biosci. 2014 Jul 25;1:6. doi: 10.3389/fmolb.2014.00006. eCollection 2014.
5
Intrinsically disordered proteins and their (disordered) proteomes in neurodegenerative disorders.神经退行性疾病中的内在无序蛋白质及其(无序)蛋白质组
Front Aging Neurosci. 2015 Mar 2;7:18. doi: 10.3389/fnagi.2015.00018. eCollection 2015.